CYP investors believe FDA approval is easy and cheap. They also believe they are odds on favourite to get FDA approval even though CYP is less than half way through the one and only FDA trial they have attempted (which is a P2).
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)